Leidos (LDOS) Reports Q3 Earnings: What Key Metrics Have to Say

04.11.25 15:30 Uhr

Werte in diesem Artikel
Aktien

161,50 EUR 0,60 EUR 0,37%

Indizes

6.603,0 PKT 64,2 PKT 0,98%

Leidos (LDOS) reported $4.47 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 6.7%. EPS of $3.05 for the same period compares to $2.93 a year ago.The reported revenue represents a surprise of +4.76% over the Zacks Consensus Estimate of $4.27 billion. With the consensus EPS estimate being $2.61, the EPS surprise was +16.86%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Leidos performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Health & Civil: $1.3 billion versus the three-analyst average estimate of $1.26 billion. The reported number represents a year-over-year change of +6.2%.Revenues- National Security and Digital: $2.02 billion versus the three-analyst average estimate of $1.89 billion. The reported number represents a year-over-year change of +8%.Revenues- Commercial & International: $571 million versus the three-analyst average estimate of $581.72 million. The reported number represents a year-over-year change of -1.2%.Revenues- Defense Systems: $582 million versus the three-analyst average estimate of $534.95 million. The reported number represents a year-over-year change of +11.5%.Operating income (loss)- Corporate: $-59 million versus $-61.92 million estimated by two analysts on average.Operating income (loss)- Defense Systems: $37 million versus the two-analyst average estimate of $34.75 million.Non-GAAP operating income (loss)- Defense Systems: $52 million versus $46.17 million estimated by two analysts on average.Operating income (loss)- National Security & Digital: $191 million versus the two-analyst average estimate of $184.75 million.Non-GAAP operating income (loss)- Health & Civil: $334 million versus the two-analyst average estimate of $260.68 million.Non-GAAP operating income (loss)- National Security and Digital: $201 million versus $184.62 million estimated by two analysts on average.Non-GAAP operating income (loss)- Commercial & International: $46 million versus the two-analyst average estimate of $47.82 million.Operating income (loss)- Health & Civil: $328 million compared to the $267.69 million average estimate based on two analysts.View all Key Company Metrics for Leidos here>>>Shares of Leidos have returned -2.5% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Leidos Holdings, Inc. (LDOS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Leidos und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Leidos

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Leidos

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Leidos Holdings Inc

Wer­bung

Analysen zu Leidos Holdings Inc

DatumRatingAnalyst
21.11.2017Leidos HoldStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
21.11.2017Leidos HoldStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Leidos Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen